Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

International IP estate further strengthened for Feraccru

6 Sep 2017

Shield Therapeutics is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a composition of matter patent protecting the active substance of Feraccru.

Please use the link provided below for the full announcement.

US Composition of Matter Patent Press Release

Back to news